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Shared genetic aetiology between cognitive functions and
physical and mental health in UK Biobank (N= 112151) and
24 GWAS consortia
SP Hagenaars1,2,3,13, SE Harris1,4,13, G Davies1,2, WD Hill1,2, DCM Liewald1,2, SJ Ritchie1,2, RE Marioni1,4,5, C Fawns-Ritchie1,2,
B Cullen6, R Malik7, METASTROKE Consortium, International Consortium for Blood Pressure GWAS, SpiroMeta Consortium,
CHARGE Consortium Pulmonary Group, CHARGE Consortium Aging and Longevity Group, BB Worrall8,9, CLM Sudlow1,4,10,
JM Wardlaw1,10, J Gallacher11, J Pell6, AM McIntosh3, DJ Smith6, CR Gale1,2,12,14 and IJ Deary1,2,14
Causes of the well-documented association between low levels of cognitive functioning and many adverse neuropsychiatric
outcomes, poorer physical health and earlier death remain unknown. We used linkage disequilibrium regression and polygenic
profile scoring to test for shared genetic aetiology between cognitive functions and neuropsychiatric disorders and physical health.
Using information provided by many published genome-wide association study consortia, we created polygenic profile scores for
24 vascular–metabolic, neuropsychiatric, physiological–anthropometric and cognitive traits in the participants of UK Biobank, a very
large population-based sample (N= 112 151). Pleiotropy between cognitive and health traits was quantified by deriving genetic
correlations using summary genome-wide association study statistics and to the method of linkage disequilibrium score regression.
Substantial and significant genetic correlations were observed between cognitive test scores in the UK Biobank sample and many
of the mental and physical health-related traits and disorders assessed here. In addition, highly significant associations were
observed between the cognitive test scores in the UK Biobank sample and many polygenic profile scores, including coronary artery
disease, stroke, Alzheimer’s disease, schizophrenia, autism, major depressive disorder, body mass index, intracranial volume, infant
head circumference and childhood cognitive ability. Where disease diagnosis was available for UK Biobank participants, we were
able to show that these results were not confounded by those who had the relevant disease. These findings indicate that a
substantial level of pleiotropy exists between cognitive abilities and many human mental and physical health disorders and traits
and that it can be used to predict phenotypic variance across samples.
Molecular Psychiatry (2016) 21, 1624–1632; doi:10.1038/mp.2015.225; published online 26 January 2016
INTRODUCTION
Cognitive functioning is positively associated with greater long-
evity and less physical and psychiatric morbidity, and negatively
associated with many quantitative disease risk factors and
indices.1 Some specific associations between cognitive functions
and health appear to arise because an illness has lowered prior
levels of cognitive function.2,3 For others, the direction of
causation appears to be the reverse: there are many examples
of associations between lower cognitive functions in youth, even
childhood, and higher risk of later mental and physical illness and
earlier death.4–8 In some cases, it is not clear whether illness
affects cognitive functioning or vice versa, or whether both are
influenced by some common factors. Many examples of these
phenotypic and cognitive–illness associations are shown in
Supplementary Table 1. Overall, the causes of these cognitive–
health associations remain unknown and warrant further investi-
gation. It is also well recognized that lower educational attainment
is associated with adverse health outcomes,9 and educational
attainment has been used as a successful proxy for cognitive
ability in genetic research.10,11 A study that included three cohorts
of twins indicated that the association between higher cognitive
function and increased lifespan was mostly owing to common
genetic effects.12
The associations between cognitive and health and illness
variables may, in part, reflect shared genetic influences. Cognitive
functions show moderate heritability,13 and so do many physical
and mental illnesses and health-associated anthropometric
measures.14 Therefore, researchers have begun to examine
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pleiotropy between scores on tests of cognitive ability and health-
related variables.15,16 Pleiotropy is the overlap between the
genetic architecture of two or more traits, perhaps owing to a
variety of shared causal pathways.17 Originally, the possibility of
pleiotropy in cognitive–health associations was tested using
family- and twin-based designs.18 However, now data from
single-nucleotide polymorphism (SNP) genotyping can assess
pleiotropy, opening the possibility for larger-scale, population-
generalizable studies.
Multiple methods can be used to test for pleiotropy using
SNP-based genetic data. Calculating genetic correlations between
health measures using the summary results of previous genome-
wide association studies (GWAS) has become possible using the
method of linkage disequilibrium (LD) score regression.19
In addition, the method of polygenic profile scoring20 also uses
summary GWAS data to test whether genetic liability to a given
illness or health-related anthropometric measurement is associated
with phenotypes such as cognitive test scores in a second
independent data set. For example, lower cognitive functioning
was associated significantly in healthy older people with higher
polygenic risk for schizophrenia21 and stroke,22 but not for
dementia.23 However, most polygenic profile studies to date have
been limited in the information they provide on this important topic:
they have reported on single health outcomes, and have used
relatively small cohorts with available cognitive data. Two recent
papers, using polygenic profile scoring and/or LD score regression,
have identified pleiotropy between a number of health-related traits
and diseases, and educational attainment15 and between a number
of psychiatric disorders and cognitive traits, and behavioural traits.16
We aimed to discover whether cognitive functioning is
associated with many physical and mental health and health-
related anthropometric measurements, in part, because of their
shared genetic aetiology using the recently released UK Biobank
genetic data (http://www.ukbiobank.ac.uk).24 We curated GWAS
meta-analyses for 24 health-related measures, and used them in
two complementary methods to test for cognitive–health
pleiotropy. First, we used LD score regression to derive genetic
correlations between cognitive function and educational attain-
ment traits measured in UK Biobank, and 24 health-related
measures from the GWAS meta-analyses. Second, to provide a
measure of the phenotypic variance that these genetic correla-
tions account for, the summary data from GWAS meta-analyses
were used to calculate polygenic profile scores in UK Biobank,
which includes cognitive, educational and genome-wide SNP data
on over 110 000 individuals. We calculated the associations
between polygenic profile scores for the 24 health-related
measures and the cognitive domains of memory, processing
speed and verbal-numerical reasoning, and educational attain-
ment in UK Biobank participants. These new data and results
provide a substantial advance in understanding the aetiology of
cognitive–health associations.
MATERIALS AND METHODS
Study design and participants
This study includes baseline data from the UK Biobank Study (http://www.
ukbiobank.ac.uk).24 UK Biobank received ethical approval from the
Research Ethics Committee. The Research Ethics Committee reference for
UK Biobank is 11/NW/0382. UK Biobank is a health resource for researchers
that aims to improve the prevention, diagnosis and treatment of a range of
illnesses. A total 502 655 community-dwelling participants aged between
37 and 73 years were recruited between 2006 and 2010 in the United
Kingdom. They underwent cognitive and physical assessments, provided
blood, urine and saliva samples for future analysis, gave detailed
information about their backgrounds and lifestyles, and agreed to have
their health followed longitudinally. For the present study, genome-wide
genotyping data were available on 112 151 individuals (58 914 females)
aged 40–73 years (mean age= 56.9 years, s.d. = 7.9) after the quality control
process (see below).
Procedures
Cognitive phenotypes. Three cognitive tests were used in the present
study. These tests, which cover three important cognitive domains, were
reaction time (n=496 891; of whom 111 484 also had genotyping data),
memory (n=498 486; 112 067 with genotyping) and verbal-numerical
reasoning (n=180 919; 36 035 with genotyping). The reaction time test
was a computerized ‘Snap’ game, in which participants were to press a
button as quickly as possible when two ‘cards’ on screen were matching.
There were eight experimental trials, with a Cronbach α reliability of 0.85.
In the memory test, participants were shown a set of 12 cards (six pairs) on
a computer screen for 5 s, and had to recall which were matching after the
cards had been obscured. We used the number of errors in this task as the
(inverse) measure of memory ability. The verbal-numerical reasoning task
involved a series of 13 items assessing verbal and arithmetical deduction
(Cronbach α reliability = 0.62). A total 492 513 participants also reported
whether or not they had a college or university degree (henceforth
referred to as ‘educational attainment’), 111 114 of whom had genotyping
data. Full details on the content and administration of each test (and the
educational attainment question) are provided in the Supplementary
Materials. Supplementary Figure 1 shows that the broad age distribution of
the cognitive tests did not differ between the full and genotyped samples.
Genotyping and quality control. A total 152 729 UK Biobank blood
samples were genotyped using either the UK BiLEVE array (N= 49 979)25
or the UK Biobank axiom array (N= 102 750). Details of the array design,
genotyping, quality control and imputation are available in a publication25
and in the Supplementary Materials. Quality control was performed by
Affymetrix, the Wellcome Trust Centre for Human Genetics, and by the
present authors; this included removal of participants based on missing-
ness, relatedness, gender mismatch, non-British ancestry and other criteria,
and is described in the Supplementary Materials.
GWAS analyses in the UK Biobank sample. GWAS analyses were performed
on the three UK Biobank cognitive test scores and on the Educational
Attainment data to use the summary results for LD score regression. Details
of the GWAS procedures are provided in the Supplementary Materials.
Curation of summary results from GWAS consortia on health-related
variables. To conduct LD score regression and polygenic profile score
analyses between the UK Biobank cognitive data and the genetic
predisposition to a large number of health-related variables, selected
because of previous associations with cognitive functions (Supplementary
Table 1), we gathered 24 sets of summary results from international GWAS
consortia. Details of the health-related variables, the consortia’s websites,
key references and number of subjects included in each consortia’s GWAS
are given in Supplementary Table 2.
Statistical analysis
Computing genetic associations between health and cognitive variables. We
used two methods to compute genetic associations between health
variables from 24 GWAS consortia, and cognitive and educational
attainment variables measured in UK Biobank: LD score regression and
polygenic profile scoring. Each provides a different metric to infer the
existence of pleiotropy between pairs of traits. LD score regression was
used to derive genetic correlations to determine the degree to which the
polygenic architecture of a trait overlaps with that of another. Next, the
polygenic profile score method was used to test the extent to which these
genetic correlations are predictive of phenotypic variance across samples.
Both LD score regression and polygenic profile scores are dependent on
the traits analysed being highly polygenic in nature, that is, where a large
number of variants of small effect contribute toward phenotypic
variation.19,20 This was tested for each trait before running the LD score
regression and polygenic profile analyses.
LD score regression. To quantify the level of pleiotropy between the traits
assessed here, LD score regression was used.15,19 LD score regression is a
class of techniques that exploits the correlational structure of the SNPs
found across the genome. In the Supplementary Materials, we provide
more details of LD score regression. Here, we use LD score regression to
derive genetic correlations between health-related and cognitive traits
using 24 large GWAS consortia data sets that enable pleiotropy of their
health-related traits to be quantified with the cognitive traits in UK Biobank.
We followed the data processing pipeline devised by Bulik-Sullivan et al.,19
described in more detail in the Supplementary Materials. To ensure that the
Pleiotropy between cognitive ability and health
SP Hagenaars et al
1625
Molecular Psychiatry (2016), 1624 – 1632
genetic correlation for the Alzheimer’s disease phenotype was not driven
by a single locus or biased the fit of the regression model, a 500 kb region
centred on the APOE locus was removed and this phenotype was re-run.
This additional model is referred to in the tables and figures below as
‘Alzheimer’s disease (500 kb)’.
Polygenic profiling. The UK Biobank genotyping data required recoding
from numeric (1, 2) allele coding to standard ACGT format before being
used in polygenic profile scoring analyses. This was achieved using a
bespoke programme developed by one of the present authors (DCML),
details of which are provided in the Supplementary Materials.
Polygenic profiles were created for 24 health-related phenotypes (see
Table 3, and Supplementary Table 1) in all genotyped participants using
PRSice.26 PRSice calculates the sum of alleles associated with the
phenotype of interest across many genetic loci, weighted by their effect
sizes estimated from a GWAS of that phenotype in an independent sample.
Before creating the scores, SNPs with a minor allele frequency o0.01 were
removed and clumping was used to obtain SNPs in linkage equilibrium
with an r2o0.25 within a 200 bp window. Multiple scores were then
created for each phenotype containing SNPs selected according to the
significance of their association with the phenotype. The GWAS summary
data for each of the 24 health-related phenotypes were used to create five
polygenic profiles in the UK Biobank participants, at thresholds of Po0.01,
Po0.05, Po0.1, Po0.5 and all SNPs.
Correlation coefficients were calculated between each of the UK Biobank
cognitive phenotypes. The associations between the polygenic profiles
and the target phenotype were examined in regression models (linear
regression for the continuous cognitive traits and logistic regression for the
binary education variable), adjusting for age at measurement, sex,
genotyping batch and array, assessment centre and the first 10 genetic
principal components to adjust for population stratification. We corrected
for multiple testing across all polygenic profile scores at all significance
thresholds for associations with all cognitive phenotypes (470 tests) using
the false discovery rate method.27 We conducted sensitivity analyses as
follows. Where the original findings were false discovery rate significant,
UK Biobank participants with cardiovascular disease (N=5300) were then
removed from analyses of coronary artery disease, those with diabetes
(N= 5800) were removed from type 2 diabetes analyses, and those with
hypertension (N= 26 912) were removed from systolic blood pressure
analyses. See Supplementary Materials for further details of these
sensitivity analysis. Four multivariate regression models were then
performed, including all 24 polygenic profile scores and the covariates
described above.
RESULTS
Phenotypic and genetic associations among the UK Biobank’s
cognitive traits
In addition to descriptive statistics, Table 1 shows phenotypic
correlations and genetic correlations (calculated using LD score
regression) among the cognitive traits in UK Biobank. There were
modest correlations between the three cognitive test scores; those
who did well on one test tended to do well on the other two.
Verbal-numerical reasoning showed the highest phenotypic
correlation with educational attainment (r= 0.30). The strongest
genetic correlation was also between verbal-numerical reasoning
and educational attainment (rg = 0.79). All but one of the other
genetic correlations were statistically significant: there was a
nonsignificant genetic correlation between educational attain-
ment and reaction time. These results show that different
cognitive traits and educational attainment correlate, in part,
due to overlapping genetic architecture.
Cognitive–health pleiotropy: overview
To test for pleiotropy between cognitive and health traits, we
present the LD score regression (Table 2, Figure 1) and polygenic
profile score (Table 3, Supplementary Tables 4a and d) results for
the four UK Biobank cognitive function and educational attainment
traits, and the 24 health-related traits from GWAS consortia. Results
are false discovery rate-corrected for multiple comparisons.
In overview, using LD score regression results, educational
attainment showed significant genetic correlations with 14 of the
22 health-related traits, verbal-numerical reasoning had significant
genetic correlations with 10 of the 24, and memory and reaction
time both correlated significantly with 3 of the 24 (Table 2,
Figure 1).
In the polygenic profile score results, using the best SNP
threshold of the five that were created, summary GWAS data
from 19 of 22 consortia predicted significant phenotypic variation
in educational attainment in the UK Biobank sample (Table 3). For
verbal-numerical reasoning, results from 15 of the 24 consortia
predicted significant phenotypic variation. The numbers for
memory and reaction time were seven and six, respectively.
The numbers of SNPs included in each polygenic threshold
score for each of the 24 health-related traits are shown in
Supplementary Table 3. The fuller results relating all five of the
SNP thresholds for all the 24 health-associated variables with the
UK Biobank cognitive phenotypes are shown in Supplementary
Tables 4a–d.
Cognitive–health pleiotropy: brain-cognitive traits
Cognitive and brain traits provided a first check before moving to
more mainstream health measures whose phenotypes appear
more distant from cognitive function. In LD score regression
analyses, we expected significant genetic correlations between
GWAS consortia results from cognitive- and brain-related traits
and the UK Biobank GWAS results for cognitive variables. In
polygenic risk score analyses, we expected the polygenic scores
based on the health-related GWAS consortia’s results to predict
phenotypic variation in UK Biobank’s cognitive traits.
Using LD score regression, genetic correlations of greater than
0.9 were found between UK Biobank’s Education Attainment
variable and GWAS consortia results from childhood cognitive
Table 1. Descriptive statistics and phenotypic (below diagonal) and genetic (above diagonal) correlations for the UK Biobank cognitive and
educational variables in all genotyped participants
Variable Mean (s.d.) Genetic/phenotypic correlation
Reaction time Memory Verbal-numerical
reasoning
Educational
attainment
Reaction time (ms) 555.08 (112.69) — 0.179 (0.06)* 0.206 (0.05)* 0.066 (0.04)
Memory (errors) 4.06 (3.23) 0.116 (0.003)* — 0.437 (0.06)* 0.126 (0.05)†
Verbal-numerical reasoning (max. score 13) 6.16 (2.10) 0.156 (0.005)* 0.176 (0.005)* — 0.729 (0.04)*
Educational attainment 30.5% with degree 0.099 (0.003)* 0.052 (0.003)* 0.338 (0.005)* —
Genetic correlations are based on the results of genome-wide association studies of the UK Biobank variables. Standard errors for the correlations are shown in
parentheses. For the phenotypic variables, Pearson correlations used for continuous–continuous correlations and point–biserial correlations for continuous–
categorical correlations. All variables are coded such that higher scores indicate better performance. *P-value o0.0001; †P-value o0.05.
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ability, college degree attainment and years of education (Table 2,
Figure 1). The genetic correlation between UK Biobank’s Educa-
tional Attainment variable and ENIGMA’s intracranial volume was
0.44 and with Early Growth Genetics Consortium’s infant head
circumference was 0.25. Verbal-numerical reasoning in UK Biobank
had a genetic correlation of 0.81 with childhood cognitive ability,
of 0.75 with attaining a college degree (Social Science Genetic
Association Consortium), 0.72 with years of education (Social
Science Genetic Association Consortium), and 0.25 with intracranial
volume. These results demonstrate substantial shared genetic
aetiology between brain size, cognitive ability and educational
attainment. Reaction time and memory did not have significant
genetic correlations with the brain, cognitive or educational
variables.
In summarizing polygenic profile analyses’ results in the text, we
shall use standardized betas (β). Polygenic profiles for higher
childhood cognitive ability and a higher level of educational
attainment (Social Science Genetic Association Consortium) were
significantly associated with increased likelihood of a college
degree (β between 0.12 and 0.28), higher scores on verbal-
numerical reasoning (β between 0.08 and 0.11), and faster
reaction time (β about 0.001). Only childhood cognitive ability
was significantly associated with memory (β= 0.01). Polygenic
profiles for greater intracranial volume and greater infant head
circumference were significantly associated with increased
likelihood of a college degree (β= 0.04 and 0.05, respectively),
and higher scores on verbal-numerical reasoning (both β= 0.02).
Cognitive–health pleiotropy: neuropsychiatric disorders
Using LD score regression, there were negative genetic correla-
tions between Alzheimer’s disease and UK Biobank’s educational
attainment variable and verbal-numerical reasoning (rg between
− 0.27 and − 0.39; Table 2, Figure 1). Autism had positive genetic
correlations with the same two Biobank variables: 0.34 for
educational attainment and 0.19 for verbal-numerical reasoning.
Bipolar disorder and schizophrenia showed a pattern of having a
positive genetic correlation with educational attainment (0.22 and
0.13, respectively) and a negative genetic correlation with verbal-
numerical reasoning (−0.11 and − 0.30, respectively). Schizophre-
nia was genetically associated with slower reaction time (−0.24)
and poorer memory (−0.34). Bipolar disorder was also genetically
associated with poorer memory (−0.24). Major depressive disorder
was genetically associated with slower reaction time (−0.25).
Table 2. Genetic correlations between the cognitive and education phenotypes documented in the UK Biobank data set and the health-related
variables collected from GWAS consortia
Health-related variables from GWAS
consortia
Verbal-numerical reasoning
(n= 36 035)
Reaction time
(n= 111 484)
Memory (n= 112 067) Educational attainment
(n=111 114)
rg s.e. P rg s.e. P rg s.e. P rg s.e. P
Vascular–metabolic diseases
Coronary artery disease − 0.086 0.062 0.163 0.058 0.066 0.378 0.058 0.074 0.430 − 0.262 0.048 5.6 ×10−8
Stroke: ischaemic − 0.231 0.092 0.012 − 0.007 0.088 0.935 0.035 0.095 0.711 − 0.168 0.066 0.011
Stroke: cardioembolic − 0.037 0.133 0.781 − 0.104 0.125 0.405 − 0.056 0.134 0.679 − 0.027 0.092 0.771
Stroke: large vessel disease − 0.408 0.187 0.029 − 0.061 0.156 0.695 0.010 0.172 0.953 − 0.336 0.145 0.020
Stroke: small vessel disease — — — — — — — — — — — —
Type 2 diabetes − 0.023 0.064 0.725 0.034 0.064 0.590 0.059 0.077 0.444 − 0.090 0.050 0.074
Neuropsychiatric disorders
ADHD − 0.334 0.147 0.023 − 0.072 0.138 0.599 − 0.043 0.159 0.788 − 0.305 0.141 0.030
Alzheimer's disease − 0.394 0.124 0.002 0.042 0.085 0.622 − 0.131 0.116 0.256 − 0.266 0.082 0.001
Alzheimer's disease (500 kb) − 0.325 0.081 6.0 ×10−5 0.036 0.070 0.603 − 0.117 0.097 0.229 − 0.223 0.057 1.0 ×10−4
Autism 0.187 0.066 0.005 − 0.160 0.067 0.016 − 0.092 0.081 0.258 0.344 0.053 6.7 ×10−11
Bipolar disorder − 0.107 0.063 0.091 − 0.131 0.066 0.048 − 0.237 0.073 0.001 0.219 0.047 4.0 ×10−6
Major depressive disorder − 0.108 0.093 0.248 − 0.248 0.087 0.004 − 0.217 0.106 0.042 − 0.103 0.082 0.213
Schizophrenia − 0.295 0.045 3.5 ×10−11 − 0.240 0.040 2.1 × 10−9 − 0.339 0.041 1.1× 10−16 0.128 0.034 1.1 ×10−16
Brain measures
Hippocampal volume − 0.040 0.107 0.710 0.222 0.124 0.073 0.014 0.132 0.916 − 0.076 0.086 0.380
Intracranial volume 0.245 0.101 0.015 − 0.175 0.098 0.073 0.084 0.114 0.463 0.442 0.084 2.0 ×10−4
Infant head circumference 0.193 0.093 0.038 − 0.048 0.080 0.547 0.103 0.097 0.287 0.248 0.069 3.0 ×10−4
Physical and physiological measures
Blood pressure: diastolic − 0.071 0.057 0.213 − 0.074 0.054 0.172 − 0.050 0.065 0.442 − 0.071 0.039 0.067
Blood pressure: systolic − 0.061 0.058 0.297 − 0.027 0.052 0.600 − 0.010 0.063 0.873 − 0.082 0.037 0.026
BMI − 0.119 0.033 2.0 ×10−4 − 0.028 0.028 0.317 0.154 0.035 1.0× 10−5 − 0.233 0.024 3.6 ×10−22
Height 0.056 0.029 0.054 0.067 0.027 0.014 − 0.017 0.033 0.609 0.120 0.024 5.0 ×10−7
Longevity 0.111 0.092 0.226 − 0.067 0.086 0.437 0.130 0.114 0.254 NA NA NA
Forced expiratory volume in 1 s
(FEV1)
0.109 0.054 0.044 − 0.061 0.048 0.209 − 0.023 0.066 0.722 NA NA NA
Life-course cognitive traits and proxies
Childhood cognitive ability 0.812 0.094 6.2 ×10−18 0.067 0.089 0.451 0.100 0.112 0.370 0.906 0.082 4.2 ×10−28
College degree 0.749 0.055 3.3 ×10−42 0.046 0.053 0.388 − 0.050 0.060 0.404 0.984 0.041 3.8 ×10−130
Years of education 0.720 0.056 2.0 ×10−38 0.031 0.048 0.523 − 0.050 0.059 0.403 0.948 0.041 1.4 ×10−115
Abbreviations: ADHD, attention deficit hyperactivity disorder; BMI, body mass index; GWAS, genome-wide association study; NA, not available; rg, genetic
correlation. Statistically significant P-values (after false discovery rate correction; threshold: Po0.016) are shown in bold. There was no evidence for a sufficient
polygenic signal in the small vessel disease data set and so no genetic correlation could be derived as shown in Supplementary Table 3.
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Polygenic profile scoring replicated the directions of association
found with LD score regression-estimated genetic correlations
(Table 3). Higher polygenic risk for Alzheimer’s disease was
associated with lower educational attainment and a lower score
on verbal-numerical reasoning and memory (β between − 0.01
and − 0.05). Higher polygenic risk for ADHD was associated with
lower educational attainment (β=−0.03). Higher polygenic risk for
autism was associated with higher educational attainment and
better verbal-numerical reasoning (β= 0.07 and 0.02, respectively).
Higher polygenic risk for bipolar disorder and schizophrenia had a
positive association with educational attainment (β= 0.06 and
0.03, respectively), and the genetic risk for schizophrenia and
major depressive disorder had a negative association with verbal-
numerical reasoning (β=− 0.06 and − 0.02, respectively).
Cognitive–health pleiotropy: vascular–metabolic diseases
There were significant negative genetic correlations between UK
Biobank’s educational attainment variable and coronary artery
disease (−0.26), ischaemic stroke (−0.17) and large vessel disease
stroke (−0.34; Table 2, Figure 1). There was a significant negative
genetic correlation between ischaemic stroke and verbal-
numerical reasoning (−0.23).
Greater polygenic risk for coronary artery disease, type 2
diabetes, and ischaemic, and large and small vessel disease
stroke were all associated with lower educational attainment
(β between − 0.02 and − 0.05). Greater polygenic risk for coronary
artery disease, and ischaemic and large vessel disease stroke
were associated with lower verbal-numerical reasoning scores
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Figure 1. Heat map of genetic correlations calculated using LD regression between cognitive phenotypes in UK Biobank and health-related
variables from GWAS consortia. Hues and colours depict, respectively, the strength and direction of the genetic correlation between the
cognitive phenotypes in UK Biobank and the health-related variables. Red and blue indicate positive and negative correlations, respectively.
Correlations with the darker shade associated with a stronger association. Based on results in Table 2. ADHD, attention deficit hyperactivity
disorder; FEV1, forced expiratory volume in 1 s; GWAS, genome-wide association study; LD, linkage disequilibrium; NA, not available.
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Table 3. Associations between polygenic profiles of health-related traits created from GWAS consortia summary data, and UK Biobank cognitive and education phenotypes controlling for age, sex,
assessment centre, genotyping batch and array and 10 principal components for population structure
Health-related variables from GWAS
consortia
Verbal-numerical reasoning
(n= 36 035)
Reaction time
(n= 111 484)
Memory
(n=112 067)
Educational attainment
(n=111 114)
Thresh β P Thresh β P Thresh β P Thresh β P
Vascular–metabolic diseases
Coronary artery disease 0.5 − 0.019 0.0002a 0.1 0.001 0.0875 0.1 − 0.004 0.2265 1 − 0.047 7.92× 10−13b
Stroke: ischaemic 0.05 − 0.014 0.0068 0.01 − 0.001 0.0791 0.01 − 0.004 0.1759 0.5 − 0.020 0.0026
Stroke: cardioembolic 1 − 0.009 0.0937 0.01 0.001 0.0817 0.01 0.005 0.0638 0.5 − 0.003 0.6931
Stroke: large vessel disease 0.01 − 0.013 0.0155 0.05 2.26 × 10− 4 0.6714 0.05 − 0.008 0.0056 0.1 − 0.031 5.31× 10−6
Stroke: small vessel disease 0.05 − 0.012 0.0250 1 − 0.001 0.3188 1 − 0.004 0.1388 0.1 − 0.034 2.96× 10−7
Type 2 diabetes 1 − 0.006 0.2490 0.1 − 4.50 × 10− 4 0.3982 0.1 0.003 0.2614 0.5 − 0.025 0.0002c
Neuropsychiatric disorders
ADHD 1 − 0.008 0.1054 1 − 0.001 0.2485 1 0.001 0.6520 1 − 0.027 4.68× 10−5
Alzheimer's disease 0.05 − 0.023 1.27× 10−5 0.5 − 0.001 0.0516 0.5 − 0.011 1.22×10−4 1 − 0.046 2.33× 10−12
Autism 1 0.023 1.43× 10−5 0.1 0.001 0.1176 0.1 0.002 0.4385 0.5 0.068 5.00× 10−25
Bipolar disorder 0.01 − 0.006 0.2695 0.01 − 0.002 0.0007 0.01 − 0.017 3.21×10−8 0.5 0.057 1.35× 10−17
Major depressive disorder 1 − 0.020 0.0002 0.1 − 0.002 0.0005 0.1 − 0.014 1.91×10−6 1 − 0.009 0.1905
Schizophrenia 0.05 − 0.062 7.73× 10−32 0.1 − 0.006 1.88×10−25 0.1 − 0.039 4.49×10−39 0.05 0.025 0.0002
Brain measures
Hippocampal volume 0.01 0.005 0.3552 0.5 0.001 0.1144 0.5 − 0.005 0.0848 0.5 0.007 0.2887
Intracranial volume 0.5 0.016 0.0021 0.01 0.001 0.3306 0.01 0.005 0.0778 1 0.043 2.91× 10−10
Infant head circumference 0.5 0.024 8.53× 10−6 0.01 − 0.001 0.0468 0.01 0.005 0.0782 0.1 0.050 4.01× 10−14
Physical and physiological measures
Blood pressure: diastolic 0.05 0.004 0.5044 0.01 0.001 0.2325 0.01 − 0.002 0.5342 0.1 − 0.022 0.0011
Blood pressure: systolic 0.1 0.013 0.0116 0.5 − 4.97 × 10− 4 0.3460 0.5 − 0.003 0.3149 0.1 − 0.035 7.61× 10−8d
BMI 0.5 − 0.027 3.34× 10−7 0.01 3.96 × 10− 4 0.4507 0.01 0.016 7.31×10−8 0.5 − 0.093 6.40× 10−45
Height 1 0.021 9.23× 10−5 0.5 4.46 × 10− 4 0.4135 0.5 0.003 0.3579 1 0.070 2.95× 10−24
Longevity 0.01 0.004 0.4091 0.05 3.23 × 10− 4 0.5426 0.05 0.006 0.0484 NA NA NA
Forced expiratory volume in 1 s (FEV1) 0.5 0.012 0.0220 0.05 − 0.001 0.1302 0.05 − 0.005 0.0840 NA NA NA
Life-course cognitive traits and proxies
Childhood cognitive ability 1 0.079 3.49× 10−51 0.5 0.002 0.0002 0.5 0.014 1.65×10−6 1 0.122 3.92× 10−75
College degree 0.5 0.102 3.19× 10−83 0.5 0.001 0.0133 0.5 − 0.002 0.4688 0.5 0.280 0
Years of education 1 0.106 2.96× 10−89 0.1 0.001 0.0156 0.1 − 0.004 0.1563 1 0.210 0
Abbreviations: ADHD, attention deficit hyperactivity disorder; BMI, body mass index; FDR, false discovery rate; GWAS, genome-wide association study; NA, not available. aExcluding individuals with
cardiovascular disease β=− 0.018, P= 0.0007. bExcluding individuals with cardiovascular disease β=− 0.044, P= 4.66× 10− 11. cExcluding individuals with diabetes β=− 0.020, P= 0.0032. dExcluding individuals
with hypertension β=− 0.028, P= 0.00016. FDR-corrected statistically significant values (Po0.0188) are shown in bold. Cognitive and education phenotypes are scored such that higher scores indicate better
performance. The associations between the polygenic profile with the largest effect size (thresh) and each cognitive and education phenotype are presented. Thresh is the P-value threshold with the largest
effect size.
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(β between − 0.01 and − 0.02). Greater polygenic risk for large
vessel disease stroke was associated with more errors in the
memory task (β=− 0.01). There was little change to the results for
coronary artery disease when individuals diagnosed with cardio-
vascular disease were removed from the analyses, and little
change for type 2 diabetes results when individuals with diabetes
were removed (Table 3).
Cognitive–health pleiotropy: physical, physiological and
anthropometric measures
There were significant genetic correlations between UK Biobank’s
educational attainment variable and body mass index (−0.23), and
height (0.12), both obtained from the GIANT Consortium. There
was a significant negative genetic correlation between body mass
index and verbal-numerical reasoning (−0.12) and a significant
positive genetic correlation with memory (0.15).
Greater polygenic risk for diastolic and systolic blood pressure
(obtained from International Consortium for Blood Pressure), and
body mass index were all associated with lower educational
attainment (β of − 0.02, − 0.04 and − 0.09, respectively). A
polygenic profile for greater height was associated with higher
educational attainment (β= 0.07). Higher verbal-numerical reason-
ing scores were associated with lower polygenic risk for body
mass index (β=− 0.03), and a polygenic profile for greater height
(β= 0.02) and higher systolic blood pressure (β= 0.01). Results for
systolic blood pressure changed little when individuals with
hypertension were removed from the analysis (Table 3).
Multivariate models predicting cognitive variance using many
polygenic profile scores
We next ran four multivariate regression models that included all
24 polygenic profile scores alongside the same covariates as were
described above. This tested whether there was redundancy
among the polygenic profile scores, and the extent to which
including them all together in a multivariate model would
improve the prediction of the cognitive phenotype. We compared
the R2 value of models including all the profile scores to models
including only the covariates. The polygenic profile scores alone
accounted for 3.33% of the variance in educational attainment of
a college or university degree, 2.26% of the variance in verbal-
numerical reasoning scores, 0.12% in reaction time and 0.16% in
memory scores. See Supplementary Table 5 for full results.
DISCUSSION
The present study has combined the power of UK Biobank’s very
large genotyped and cognitively tested sample with the summary
results of 24 large international GWAS consortia of physical and
mental disorders and health-related traits. Two methods—LD
score regression and polygenic profile scoring based on previous
GWAS findings—discovered extensive cognitive–health pleiotropy
and showed that it can be used to predict phenotypic variance
between GWAS data sets. Our results provide comprehensive new
findings on the overlaps between phenotypic cognitive ability
levels, genetic bases for health-related characteristics such as
height and blood pressure, and liabilities to physical and
psychiatric disorders even in mostly healthy, non-diagnosed
individuals. They make important steps toward understanding
the specific patterns of overlap between biological influences on
health and their consequences for key cognitive abilities. For
example, some of the association between educational attainment
—often used as a social background indicator—and health
appears to have a genetic aetiology. These results should
stimulate further research that will be informative about the
specific genetic mechanisms of the associations found here, which
likely involves both protective and detrimental effects of different
genetic variants.
Findings for polygenic risk for coronary artery disease were not
confounded by individuals with a diagnosis of cardiovascular
disease, findings for type 2 diabetes were not confounded by
individuals with a diagnosis of diabetes and findings for systolic
blood pressure were not confounded by individuals with a
diagnosis of hypertension. These results indicate that even in
healthy individuals, being at high polygenic risk for coronary
artery disease, type 2 diabetes or high blood pressure is associated
with lower cognitive function and lower educational attainment.
Using LD score regression, we quantified for the genetic
correlations from molecular genetic evidence between tests of
cognitive ability and a wealth of health and anthropometric traits
in over 100 000 individuals. As shown in Table 2, verbal-numerical
reasoning and educational attainment showed a greater degree of
pleiotropy than reaction time and memory, with many of the
health and anthropometric variables studied here. Novel genetic
correlations were quantified between cognitive function, using
verbal-numerical reasoning, and schizophrenia, Alzheimer’s dis-
ease and ischaemic stroke. It has not escaped our notice that there
are multiple possible interpretations of these genetic correlations.
Not only might particular genes contribute both to cognitive and
health-related traits, but genetic variants relating to health
conditions could have indirect effects on cognitive ability (for
example, via medications used to treat disorders), and vice versa
(for example, via cognitively associated lifestyle choices). See
Solovieff et al.17 for discussion of these issues of causality and
pleiotropy.
Perhaps counter-intuitively, our results indicated that the
genetic variants associated with obtaining a college degree were
also related to higher genetic risk of schizophrenia, bipolar
disorder and autism, which for bipolar disorder and autism
support the findings from a previous study.15 For the cognitive
tests, only polygenic risk for autism was related with higher
cognitive ability, in agreement with a previous study.28 Genes
related to bipolar disorder were negatively related to all of the
cognitive tests, and genes related to schizophrenia even more so.
Previous epidemiological studies indicate that both very high and
very low educational achievement is associated with an increased
risk of bipolar disorder29 and high polygenic risk of schizophrenia
and bipolar disorder were recently associated with higher levels of
creativity.30 The discrepancy between the cognitive and educa-
tional results may be explained by the age of the participants: if
schizophrenia genes are detrimental to cognitive functioning only
later in life, they may have differential effects on educational
attainment, which tends to peak before age 30, and the cognitive
tests, which were taken in UK Biobank at an average age of 56.9
years. It should also be noted the UK Biobank sample consists of
individuals who are, on average, older than those in most
schizophrenia genetic studies, have a higher level of education
and are of a higher social class. It is also likely to have been the
case that individuals in middle age with a history of serious mental
illness will have been less likely than those without such a history
to volunteer as UK Biobank participants. These demographic and
clinical factors might have contributed to apparently contradictory
findings with respect to cognitive function and previous educa-
tional attainment.
The educational attainment variable demonstrated pleiotropy
with 20 of the 24 health-related variables, indicating that the
genetic variants that collectively act to facilitate an individual’s
progress through the educational system to degree level make
important contributions to many important health outcomes. One
explanation for this is that the educational attainment variable
shows the greatest degree of pleiotropy with general cognitive
ability in childhood with a genetic correlation of 0.906. This could
indicate that it is genes related to cognitive ability early in life that
are responsible for the pleiotropy with health variables: educa-
tional attainment, therefore, might act as a proxy phenotype for
general cognitive ability, as others have demonstrated.8
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The significant genetic correlations across traits enabled the use
of polygenic profile scores to predict phenotypic cognitive
variance in the UK Biobank sample. The amount of variance
explained by the polygenic profile scores for each UK Biobank
cognitive phenotype is small, as would be expected by the fact
that not all SNPs were genotyped, and those that were do not
necessarily accurately tag the causal genetic variants. The multi-
variate polygenic risk score analyses showed that additional
variance can be accounted for when the polygenic liabilities of
multiple disorders and traits are combined; this implies that there
are risk alleles unique to each disorder and trait that affect
cognitive and educational traits.
The results of the present study are supported by a previous
study examining the genetic associations between polygenic
profile scores for psychiatric and cognitive traits, and many
phenotypic traits, showing comparable directions of effect.16
However, owing to the much smaller sample size (3000 versus
112 000 in the present study), the previous study yields
insufficient power to detect several of the associations found in
the present study. The same previous study also supported the
results of the LD regression analyses of the present study between
several psychiatric and cognitive traits, but the following traits
show novel associations with cognitive ability and educational
attainment in the present study: ischaemic stroke, infant head
circumference and years of education.
The polygenic profile analysis replicated previous, smaller studies
that showed associations between higher cognitive function and
higher polygenic risk for autism28 and lower polygenic risk for
schizophrenia21 and stroke.22 We did not replicate the previous
finding that higher cognitive function is associated with higher type
2 diabetes genetic risk,31 but we did find that higher type 2
diabetes genetic risk is associated with decreased likelihood of
obtaining a college degree. Unlike a previous small, underpowered,
study23 we found that higher polygenic risk for Alzheimer’s disease
is associated with lower cognitive function.
To the extent that these genetic associations between cognitive
and health measures are explained by shared genetic influences,
they support the theoretical construct of bodily system integrity.32
System integrity was formulated as a latent trait which is manifest
as individual differences in how effectively people meet cognitive
and health challenges from the environment, and which has some
genetic aetiology. Although it is recognized that some illnesses
will cause changes in cognitive functions, system integrity
suggests, in addition, that there is shared variance in how well
different complex bodily systems operate and that this underlies
correlations between higher cognitive functioning and good
health and longevity.
The present study has a number of strengths. First, the large
sample size of UK Biobank (N4100 000) affords powerful, robust
tests of genetic association. Second, the participants took identical
cognitive tests, which were always administered in the same
computerized fashion, reducing any potential bias owing to
heterogeneity in test content and administration. Third, all of the
UK Biobank genetic data were processed in a consistent matter,
on the same platform and at the same location. Fourth, our use of
summary data from a large number of international GWAS studies
allowed a comprehensive and detailed examination of shared
genetic aetiology with cognitive ability across a wide range of
health-related phenotypes, producing many of the first estimates
of the genetic correlation between traits.
The present study has some limitations. The three cognitive
tests were brief, bespoke measures. However, they covered three
major cognitive domains (reasoning, processing speed and
memory), showed acceptable internal consistency and had validity
in that they showed the expected correlations with one another
and with age and educational attainment.33,34 The verbal-
numerical reasoning test has types of item that are the same as
those found in tests of general cognitive ability. In addition,
verbal-numerical reasoning and educational attainment showed
strong genetic correlations (0.812 and 0.906, respectively) with
childhood general cognitive function. This suggests that the
variance in these traits is largely the product of the same genetic
variants that underpin general cognitive function. The GWAS
studies we curated to perform LD score regression and extract the
polygenic profile scores were often consortia studies, involving
meta-analyses across data sets with substantial heterogeneity in
sample size, genome-wide imputation quality and phenotypic
measurement. We expect that, with larger and more consistent
independent data sets, we would be able to use the polygenic
profile scores to predict more variance in cognitive test
performance. Some of the GWAS consortia studies did not have
ethical approval to be used for genetic correlation and polygenic
profile scoring analyses associated with education, meaning that
we were unable to estimate a few correlations. Clustering in
genetic population structure meant that we restricted the
genotyped samples to individuals of white British ancestry. Our
results thus need to be replicated in large samples of different
genetic backgrounds; the sample sizes available in UK Biobank
were not large enough for us to model, with adequate power, data
from UK Biobank individuals of other ancestries.
The best method for showing pleiotropy using GWAS data
would be to obtain the genome-wide significant hits from two
GWAS and correlate the effect sizes. However, there are two
reasons why this is suboptimal at present. The first reason is that
many significant SNP hits are needed in multiple GWAS data sets,
which is currently not possible. The second reason is that GCTA
has shown that many true associations do not reach statistical
significance owing to low power, therefore, SNPs that do not
attain statistical significance should also be considered. Both LD
regression and polygenic profile score analyses provide the
opportunity to use the full GWAS output to examine pleiotropy.
Because the optimum number of SNPs used to generate a
particular polygenic profile can differ between traits, we created
five profile scores per physical and mental health trait and tested
each in a regression against each of the UK Biobank cognitive
traits to determine the score that explained the greatest variance
in each cognitive trait. We found that these did differ between
different trait combinations, suggesting that the amount of shared
genetic aetiology differs between different pairs of traits.
However, as pleiotropy was quantified using LD score regression
to perform a single test for each pair of phenotypes, the multiple
testing problems associated with the polygenic profile score
method did not confound the estimates of pleiotropy shown here.
Although the estimate of phenotypic variance explained by the
polygenic profile method was small, this should be considered as
the minimum estimate of the variance explained. Owing to
pruning SNPs in LD, the PGRS method makes the assumption of a
single causal variant being tagged in each LD block considered. If
this assumption is not true for the phenotypes considered, the
proportion of variance explained will be underestimated here.
CONCLUSION
It is notable that, a short while ago, a single result from several of
the findings reported here would have been considered a major
novel finding and reported as a study in itself.20 With so many
findings, it has not been possible fully to discuss their implications.
For example, the genetic associations between infant head
circumference and intracranial volume with educational
attainment and verbal-numerical reasoning are important in
themselves, as are many other cognitive–mental health and
cognitive–physical health associations. Taken all together, these
results provide a resource that advances the study of aetiology in
cognitive epidemiology substantially.
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